GRANATO, MARISA
 Distribuzione geografica
Continente #
AS - Asia 260
NA - Nord America 96
EU - Europa 38
SA - Sud America 2
Totale 396
Nazione #
CN - Cina 124
US - Stati Uniti d'America 96
SG - Singapore 93
TR - Turchia 35
IT - Italia 23
DE - Germania 8
HK - Hong Kong 6
RU - Federazione Russa 3
BR - Brasile 2
FI - Finlandia 2
JP - Giappone 2
FR - Francia 1
NL - Olanda 1
Totale 396
Città #
Santa Clara 43
Singapore 25
Shanghai 21
Assago 12
Ashburn 8
Guangzhou 7
Los Angeles 7
Frankfurt am Main 6
Hong Kong 6
Jiaxing 6
Shenzhen 4
Xi'an 4
Beijing 3
Dongyang 3
Rome 3
Clifton 2
Council Bluffs 2
Dallas 2
Fuzhou 2
Helsinki 2
Kyoto 2
Nantong 2
Nanyang 2
Xuzhou 2
Cangzhou 1
Carol Stream 1
Dalian 1
Gravina di Catania 1
Guarujá 1
Handan 1
Hangzhou 1
Lagoa Santa 1
Meppel 1
Quanzhou 1
Seattle 1
Secaucus 1
Shijiazhuang 1
Tangshan 1
The Dalles 1
Turin 1
Vladivostok 1
Wuhan 1
Wuhu 1
Yoshkar-Ola 1
Totale 196
Nome #
Quercetin Interrupts the Positive Feedback Loop Between STAT3 and IL-6, Promotes Autophagy, and Reduces ROS, Preventing EBV-Driven B Cell Immortalization 19
Quercetin induces apoptosis and autophagy in primary effusion lymphoma cells by inhibiting PI3K/AKT/mTOR and STAT3 signaling pathways 18
Tyrosine kinase inhibitor tyrphostin AG490 triggers both apoptosis and autophagy by reducing HSF1 and Mcl-1 in PEL cells 16
Hyperglycemia triggers HIPK2 protein degradation 15
KSHV infection skews macrophage polarisation towards M2-like/TAM and activates Ire1 α-XBP1 axis up-regulating pro-tumorigenic cytokine release and PD-L1 expression 15
PKC theta and p38 MAPK activate the EBV lytic cycle through autophagy induction 14
Mutant p53, Stabilized by Its Interplay with HSP90, Activates a Positive Feed-Back Loop Between NRF2 and p62 that Induces Chemo-Resistance to Apigenin in Pancreatic Cancer Cells 14
Interference with the Autophagic Process as a Viral Strategy to Escape from the Immune Control: Lesson from Gamma Herpesviruses 14
JNK and macroautophagy activation by bortezomib has a pro-survival effect in primary effusion lymphoma cells 13
HCV derived from sera of HCV-infected patients induces pro-fibrotic effects in human primary fibroblasts by activating GLI2 13
Oxidant species are involved in T/B-mediated ERK1/2 phosphorylation that activates p53-p21 axis to promote KSHV lytic cycle in PEL cells 13
EBV reduces autophagy, intracellular ROS and mitochondria to impair monocyte survival and differentiation 12
EBV up-regulates PD-L1 on the surface of primary monocytes by increasing ROS and activating TLR signaling and STAT3 12
Impact of HHV-6A and HHV-6B lytic infection on autophagy and endoplasmic reticulum stress 12
High glucose and hyperglycemic sera from type 2 diabetic patients impair DC differentiation by inducing ROS and activating Wnt/β-catenin and p38 MAPK 12
Zinc supplementation is required for the cytotoxic and immunogenic effects of chemotherapy in chemoresistant p53-functionally deficient cells 12
Deletion of Epstein-Barr virus BFLF2 leads to impaired viral DNA packaging and primary egress as well as to the production of defective viral particles 11
Nanotechnology Frontiers in γ-Herpesviruses Treatments 11
KSHV ORF67 encoded lytic protein localizes on the nuclear membrane and alters emerin distribution 11
Targeting of prosurvival pathways as therapeutic approaches against primary effusion lymphomas: past, present, and Future 11
Prevalence of infection by HHV-8, HIV, HCV and HBV among pregnant women in Burkina Faso 10
Bortezomib promotes KHSV and EBV lytic cycle by activating JNK and autophagy 10
Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death 10
STAT3 phosphorylation affects p53/p21 axis and KSHV lytic cycle activation 10
Kaposi Sarcoma Herpes Virus (KSHV) infection inhibits macrophage formation and survival by counteracting Macrophage Colony-Stimulating Factor (M-CSF)-induced increase of Reactive Oxygen Species (ROS), c-Jun N-terminal kinase (JNK) phosphorylation and autophagy 10
Sourcing the immune system to induce immunogenic cell death in Kras-colorectal cancer cells 10
HSP70 inhibition by 2-phenylethynesulfonamide induces lysosomal cathepsin D release and immunogenic cell death in primary effusion lymphoma 10
Regulation of the expression of the Epstein-Barr virus early gene BFRF1 10
Epstein-barr virus blocks the autophagic flux and appropriates the autophagic machinery to enhance viral replication 9
Hepatitis C virus present in the sera of infected patients interferes with the autophagic process of monocytes impairing their in-vitro differentiation into dendritic cells 8
Cytotoxic Drugs Activate KSHV Lytic Cycle in Latently Infected PEL Cells by Inducing a Moderate ROS Increase Controlled by HSF1, NRF2 and p62/SQSTM1 8
Ultrastructural Changes of Neuroendocrine Pheochromocytoma Cell Line PC-12 Exposed In Vitro to Rotenone 8
The activation of KSHV lytic cycle blocks autophagy in PEL cells 8
Kaposi sarcoma associated herpesvirus (KSHV) induces AKT hyperphosphorylation, bortezomib-resistance and GLUT-1 plasma membrane exposure in THP-1 monocytic cell line 8
Chloroquine supplementation increases the cytotoxic effect of curcumin against Her2/neu overexpressing breast cancer cells in vitro and in vivo in nude mice while counteracts it in immune competent mice 8
Identification and characterization of the product encoded by ORF69 of Kaposi's sarcoma-associated herpesvirus 8
HHV-8 reduces dendritic cell migration through down-regulation of cell-surface CCR6 and CCR7 and cytoskeleton reorganization 8
Metformin triggers apoptosis in PEL cells and alters bortezomib-induced Unfolded Protein Response increasing its cytotoxicity and inhibiting KSHV lytic cycle activation 8
Characterization and intracellular localization of the Epstein-Barr virus protein BFLF2: interactions with BFRF1 and with the nuclear lamina 8
STAT3 activation by KSHV correlates with IL-10, IL-6 and IL-23 release and an autophagic block in dendritic cells 7
Totale 444
Categoria #
all - tutte 8.617
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.617


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202350 0 0 0 0 0 0 0 12 32 1 5 0
2023/202496 0 0 1 0 3 7 1 1 5 9 15 54
2024/2025298 32 43 68 5 4 60 44 19 19 4 0 0
Totale 444